Evaluation of the Efficacy of "Lifespan Integration" (LI) Therapy in Patients With Complex Post-Traumatic Stress Disorder

NCT ID: NCT06535243

Last Updated: 2024-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-01

Study Completion Date

2027-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to evaluate the efficacy of a relatively new type of psychotherapy called Lifespan Integration (LI) in patients suffering of complex PTSD

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Traumatic Stress Disorder Complex Psychiatric Disorder Abuse Neglect Abuse Physical Abuse, Sexual Abuse Domestic Abuse Verbal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

eligible candidates to be included in this cohort should be

* older than 18 yo
* French speaking
* with a diagnosis of complex PTSD as confirmed by 1/clinical interview with a trained psychiatrist and 2/ scores for the International Trauma Questionnaire (ITQ), clinical tool based on the ICM 11 criteria
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LI Therapy

LI Therapy will be delivered in two recruiting centers by experienced LI Therapy trained psychologists or psychiatrists (a minimum level three of training is required) The intervention will consist in delivering 15 "Basic" Protocol therapy sessions targeting symptoms of complex PTSD The study contains one single arm. One extra-session called PTSD protocol could be optionally delivered if the patient had a very recent trauma that could exacerbate his PTSD symptoms. This session is delivered in the beginning of the research protocol.

Group Type EXPERIMENTAL

Lifespan Integration Therapy (LI)

Intervention Type BEHAVIORAL

same as above

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lifespan Integration Therapy (LI)

same as above

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients diagnosed with complex PTSD
* French speaking
* first time following an LI type of therapy
* psychotropic treatment is allowed

Exclusion Criteria

* no other parallel psychotherapy is accepted (if the patient underwent recently any other type of psychotherapy, a "wash out " period of minimum 4 weeks is required )
* no active manic episode at the time of inclusion
* no active psychotic episode at the time of inclusion
* no chronic psychotic disorder diagnosis
* no autistic spectrum disorder diagnosis ,
* no intellectual deficit
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier St Anne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alexandru GAMAN

Medic Doctor MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexandru GAMAN, MD

Role: PRINCIPAL_INVESTIGATOR

GHU Paris Hôpital St Anne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU St Anne

Paris, Île-de-France Region, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hayat OUATAH

Role: CONTACT

+331 45 65 84 86

Naoual KHALFI

Role: CONTACT

+33145658486

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexandru GAMAN, MD

Role: primary

+33658981274

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D21-P019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD
NCT06954025 ENROLLING_BY_INVITATION PHASE2